[1]
I. Soltanova, “IMMUNOHISTOCHEMICAL DIAGNOSTICS OF PROGRAMMED DEATH-LIGAND-1 AND CYCLOOXYGENASE-2 RECEPTORS IN CERVICAL NEOPLASIA: POSSIBILITIES OF A DIFFERENTIATED APPROACH”, AMJ, no. 3, pp. 116–121, Sept. 2021.